The Time Course of Tumor Necrosis Factor-α, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor Expression in an Experimental Model of Chronic Myocardial Infarction in Rats
- 25 May 2001
- journal article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 38 (3) , 288-300
- https://doi.org/10.1159/000051057
Abstract
An injury to the heart due to myocardial infarction may progress to heart failure. Among the cytokines and growth factors whose interactions promote remodeling of the heart, increased expression of tumor necrosis factor (TNF)-α, inducible nitric oxide synthase (iNOS) and vascular endothelial growth factor (VEGF) has been found. However, little is known about the sequence of gene expression during the progression of heart injury. In the present study, male Sprague-Dawley rats were used for experimental myocardial infarction performed by ligation of the left anterior descending coronary artery. TNF-α, iNOS and VEGF expression was assessed by reverse transcription polymerase chain reaction. Localization of TNF-α, VEGF and iNOS protein was assessed by immunohistochemistry. An in vitro proliferation (BrdU incorporation) and differentiation (tube formation) assay of human umbilical vein endothelial cells was performed. The expression of TNF-α, iNOS, VEGF164 and VEGF188 was observed during the whole period after myocardial infarction (on days 1, 4, 11, 28 and 40), whereas VEGF120 was found only on day 1 and 4. The most intense immunostaining for TNF-α was observed at the border zone. The iNOS immunostaining was initially located in the endothelium, whereas later it was also present in the walls of larger vessels. The VEGF protein was present in the border zone. No gene expression or immunostaining was detected in sham-operated rats. The in vitro experiments showed both proangiogenic (low TNF-α concentration, short period of incubation) and antiangiogenic (high TNF-α concentration, long period of incubation) effects of TNF-α. The expression of TNF-α and iNOS genes with the concomitant occurrence of a decrease in VEGF120, VEGF188 and VEGF164 protein could be related to insufficient angiogenesis and may suggest the possible involvement of these events in remodeling after myocardial infarction.Keywords
This publication has 6 references indexed in Scilit:
- Therapeutic angiogenesis for heart failureNature Medicine, 1999
- Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188Nature Medicine, 1999
- Growth regulation of cultured endothelial cells by inflammatory cytokines: mitogenic, anti-proliferative and cytotoxic effectsComparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 1998
- Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)Journal of Biological Chemistry, 1996
- p53 expression in nitric oxide‐induced apoptosisFEBS Letters, 1994
- Indispensable Role of Tissue-Type Plasminogen Activator in Growth Factor-Dependent Tube Formation of Human Microvascular Endothelial Cells in VitroExperimental Cell Research, 1993